 |
|
PHARMACOLOGIE CARDIOVASCULAIRE
Léquipe de recherche en pharmacologie cardiovasculaire
concentre ses activités en pharmacologie fondamentale
et clinique. La recherche fondamentale porte sur les
peptides (angiotensine, tachykinines, endothélines,
etc.) et les lipides (prostaglandines, leucotriènes,
etc.) bioactifs alors que la recherche clinique sintéresse
aux mêmes substances dans linsuffisance
cardiaque et au cours de la chirurgie cardiaque. Les
domaines dintérêt vont de lhypertension
à langine et autres maladies cardiovasculaires.
Deux des chercheurs font partie des Instituts canadiens
de recherche en santé sur létude
des interactions immuno-cardiovasculaires reliées
à lathérosclérose et lhypertension.
|
 |
| L'ÉQUIPE |
 |
|
|
Bkaily,
Ghassan, Ph. D.; Boulay,
Guylain, Ph. D.; DOrléans-Juste,
Pedro, Ph. D.*; Dumaine,
Robert, Ph. D.; Escher,
Emanuel, Ph. D.; Gobeil,
Fernand Jr, Ph. D.; Guillemette,
Gaëtan, Ph. D.; Leduc,
Richard, Ph. D.; Lepage,
Serge, M.D.; Pape,
Paul C., Ph. D.; Plante,
Gérard E., M.D., Ph. D.;.
Regoli, Domenico C., M.D.; Sirois,
Pierre, Ph. D.
*Directeur
|
|
| QUELQUES RÉALISATIONS |
 |
|
|
Octroi d'un chercheur-boursier FRSQ (2005-2006), volet
recherche fondamentale à Robert Dumaine
pour son projet Identification et rôle des canaux
sodiques de type neuronaux dans le coeur;
aussi à Fernand Gobeil Jr (2004-2005)
pour son projet Rôles modulateurs des récepteurs
nucléaires des kinines sur l'expression des gènes
iNOS et COX-2.
Richard Leduc, récipiendaire
d'une bourse Chercheurs nationaux pour 4 ans du FRSQ.
Le Dr Gérard Plante siège
à titre de président du comité
d'éthique de la recherche en santé chez
l'humain du CHUS.
|
|
| Bourses
et subventions 04-05* |
1 230 198
$ |
| Publications
2004 |
40 |
| Étudiants
de 2e cycle |
26 |
| Étudiants
de 3e cycle |
28 |
| Stagiaires
postdoctoraux |
3 |
*Tiré du registre des centres
FRSQ au 05 janvier 2006
|
|
| PUBLICATIONS 2005 |
 |
|
|
Publications antérieures
Auger-Messier M, Turgeon ES, Leduc R,
Escher E, Guillemette G.
The constitutively active N111G-AT1 receptor for angiotensin
II modifies the morphology and cytoskeletal organization
of HEK-293 cells., Exp Cell Res. 2005 Aug 1;308(1):188-95.
Bkaily G, El-Bizri N, Nader M, Hazzouri
KM, Riopel J, Jacques D, Regoli D,
D'Orleans-Juste P, Gobeil F
Jr, Avedanian L. Angiotensin II induced increase
in frequency of cytosolic and nuclear calcium waves
of heart cells via activation of AT1 and AT2 receptors.,
Peptides. 2005 Aug;26(8):1418-26.
Bkaily G, Sculptoreanu A, Wang S, Nader
M, Hazzouri KM, Jacques D, Regoli D,
D'Orleans-Juste P, Avedanian L. Angiotensin
II-induced increase of T-type Ca2+ current and decrease
of L-type Ca2+ current in heart cells., Peptides. 2005
Aug;26(8):1410-7.
Blais PA, Cote J, Morin J, Larouche A, Gendron G, Fortier
A, Regoli D, Neugebauer W, Gobeil
F Jr. Hypotensive effects of hemopressin and
bradykinin in rabbits, rats and mice. A comparative
study., Peptides. 2005 Aug;26(8):1317-22.
Brosseau JP, D'Orleans-Juste P, Neugebauer
WA.. Development of an efficient strategy for the synthesis
of the ETB receptor antagonist BQ-788 and some related
analogues., Peptides. 2005 Aug;26(8):1441-53.
Brugada R, Hong K, Cordeiro JM, Dumaine R.
Short QT syndrome., CMAJ. 2005 Nov 22;173(11):1349-54.
Review.
Chahine M, Bkaily G, Nader M, Al-Khoury
J, Jacques D, Beier N, Scholz W. NHE-1-dependent intracellular
sodium overload in hypertrophic hereditary cardiomyopathy:
prevention by NHE-1 inhibitor., J Mol Cell Cardiol.
2005 Apr;38(4):571-82.
Clement M, Martin SS, Beaulieu ME, Chamberland C, Lavigne
P, Leduc R, Guillemette
G, Escher E. Determining the
environment of the ligand binding pocket of the human
angiotensin II type I (hAT1) receptor using the methionine
proximity assay., J Biol Chem. 2005 Jul 22;280(29):27121-9
Cordeiro JM, Brugada R, Wu YS, Hong K, Dumaine
R. Modulation of I(Kr) inactivation by mutation
N588K in KCNH2: a link to arrhythmogenesis in short
QT syndrome., Cardiovasc Res. 2005 Aug 15;67(3):498-509.
Daull P, Benrezzak O, Arsenault D, Pheng LH, Blouin
A, Cayer J, Beaudoin M, Belleville K, Sirois
P, Nantel F, Jeng AY, Battistini B. Triple
vasopeptidase inhibition normalizes blood pressure in
conscious, unrestrained, and spontaneously hypertensive
rats, Am J Hypertens. 2005 Dec;18(12):1606-13.
Daull P, Blouin A, Cayer J, Beaudoin M, Belleville K,
Sirois P, Nantel F, Chang TM, Battistini
B.. Profiling biochemical and hemodynamic markers using
chronically instrumented, conscious and unrestrained
rats undergoing severe, acute controlled hemorrhagic
hypovolemic shock as an integrated in-vivo model system
to assess new blood substitutes., Vascul Pharmacol.
2005 Oct;43(4):289-301
Dufour EK, Desilets A, Longpre JM, Leduc R.
Stability of mutant serpin/furin complexes: dependence
on pH and regulation at the deacylation step., Protein
Sci. 2005 Feb;14(2):303-15.
Fabricio AS, Rae GA, D'Orleans-Juste P,
Souza GE. Endothelin-1 as a central mediator of LPS-induced
fever in rats., Brain Res. 2005 Dec 20;1066(1-2):92-100.
Fabricio AS, Rae GA, Zampronio AR, D'Orleans-Juste
P, Souza GE.. Central endothelin ETB receptors
mediate IL-1-dependent fever induced by preformed pyrogenic
factor and corticotropin-releasing factor in the rat.,
Am J Physiol Regul Integr Comp Physiol. 2006 Jan;290(1):R164-71.
Fecteau MH, Honore JC, Plante M, Labonte J, Rae GA,
D'Orleans-Juste P. Endothelin-1 (1-31)
is an intermediate in the production of endothelin-1
after big endothelin-1 administration in vivo., Hypertension.
2005 Jul;46(1):87-92.
Gabra BH, Benrezzak O, Pheng LH, Duta D, Daull P, Sirois
P, Nantel F, Battistini B.. Inhibition of type
1 diabetic hyperalgesia in streptozotocin-induced Wistar
versus spontaneous gene-prone BB/Worchester rats: efficacy
of a selective bradykinin B1 receptor antagonist., J
Neuropathol Exp Neurol. 2005 Sep;64(9):782-9.
Gendron G, Gobeil F Jr, Belanger S,
Gagnon S, Regoli D, D'Orleans-Juste
P. Urotensin II-induced hypotensive responses
in Wistar-Kyoto (Wky) and spontaneously hypertensive
(Shr) rats., Peptides. 2005 Aug;26(8):1468-74.
Guillemette J, Caron AZ, Regimbald-Dumas Y, Arguin G,
Mignery GA, Boulay G, Guillemette
G. Expression of a truncated form of inositol
1,4,5-trisphosphate receptor type III in the cytosol
of DT40 triple inositol 1,4,5-trisphosphate receptor-knockout
cells., Cell Calcium. 2005 Feb;37(2):97-104.
Hardy P, Beauchamp M, Sennlaub F, Gobeil F Jr,
Tremblay L, Mwaikambo B, Lachapelle P, Chemtob S. New
insights into the retinal circulation: inflammatory
lipid mediators in ischemic retinopathy., Prostaglandins
Leukot Essent Fatty Acids. 2005 May;72(5):301-25. Review.
Haufe V, Camacho JA, Dumaine R, Gunther
B, Bollensdorff C, von Banchet GS, Benndorf K, Zimmer
T.. Expression pattern of neuronal and skeletal muscle
voltage-gated Na+ channels in the developing mouse heart.,
J Physiol. 2005 May 1;564(Pt 3):683-96.
Haufe V, Cordeiro JM, Zimmer T, Wu YS, Schiccitano S,
Benndorf K, Dumaine R. Contribution
of neuronal sodium channels to the cardiac fast sodium
current INa is greater in dog heart Purkinje fibers
than in ventricles., Cardiovasc Res. 2005 Jan 1;65(1):117-27.
Hebert RL, Regoli D, Xiong H, Breyer
MD, Plante GE. Bradykinin B2 type receptor activation
regulates fluid and electrolyte transport in the rabbit
kidney., Peptides. 2005 Aug;26(8):1308-16.
Hong K, Guerchicoff A, Pollevick GD, Oliva A, Dumaine
R, de Zutter M, Burashnikov E, Wu YS, Brugada
J, Brugada P, Brugada R.. Cryptic 5' splice site activation
in SCN5A associated with Brugada syndrome., J Mol Cell
Cardiol. 2005 Apr;38(4):555-60.
Honore JC, Fecteau MH, Brochu I, Labonte J, Bkaily
G, D'Orleans-Juste P. Concom
itant antagonism of endothelial and vascular smooth
muscle cell ETB receptors for endothelin induces hypertension
in the hamster., Am J Physiol Heart Circ Physiol. 2005
Sep;289(3):H1258-64.
Kermorvant-Duchemin E, Sennlaub F, Sirinyan M, Brault
S, Andelfinger G, Kooli A, Germain S, Ong H, d'Orleans-Juste
P, Gobeil F, Zhu T, Boisvert
C, Hardy P, Jain K, Falck JR, Balazy M, Chemtob S..
Trans-arachidonic acids generated during nitrative stress
induce a thrombospondin-1-dependent microvascular degeneration.,
Nat Med. 2005 Dec;11(12):1339-45.
Kraetke O, Holeran B, Berger H, Escher E,
Bienert M, Beyermann M.. Photoaffinity cross-linking
of the corticotropin-releasing factor receptor type
1 with photoreactive urocortin analogues., Biochemistry.
2005 Nov 29;44(47):15569-77.
Laflamme K, Roberge CJ, Labonte J, Pouliot S, D'Orleans-Juste
P, Auger FA, Germain L.. Tissue-engineered
human vascular media with a functional endothelin system.,
Circulation. 2005 Feb 1;111(4):459-64.
Lanctot PM, Leclerc PC, Clement M, Auger-Messier M,
Escher E, Leduc R,
Guillemette G. Importance of N-glycosylation
positioning for cell-surface expression, targeting,
affinity and quality control of the human AT1 receptor,
Biochem J. 2005 Aug 15;390(Pt 1):367-76.
Lessard CB, Lussier MP, Cayouette S, Bourque G, Boulay
G. The overexpression of presenilin2 and Alzheimer's-disease-linked
presenilin2 variants influences TRPC6-enhanced Ca2+
entry into HEK293 cells, Cell Signal. 2005 Apr;17(4):437-45.
Lussier MP, Cayouette S, Lepage PK, Bernier CL, Francoeur
N, St-Hilaire M, Pinard M, Boulay G.
MxA, a member of the dynamin superfamily, interacts
with the ankyrin-like repeat domain of TRPC., J Biol
Chem. 2005 May 13;280(19):19393-400.
Menard J, Payette H, Baillargeon JP, Maheux
P, Lepage S, Tessier D, Ardilouze
JL.. Efficacy of intensive multitherapy for patients
with type 2 diabetes mellitus: a randomized controlled
trial., CMAJ. 2005 Dec 6;173(12):1457-66.
Methogo RM, Dufresne-Martin G, Leclerc P, Leduc
R, Klarskov K.. Mass spectrometric
peptide fingerprinting of proteins after Western blotting
on polyvinylidene fluoride and enhanced chemiluminescence
detection., J Proteome Res. 2005 Nov-Dec;4(6):2216-24.
Moris MA, Caron AZ, Guillemette G,
Rognan D, Schmitt M, Schlewer G. Synthesis of (+/-)-2-O-[4'-(N-9''-purinyl)butyl]
myo-inositol 1,4,5-tris(phosphate), a potent full agonist
at the D-myo-inositol 1,4,5-tris(phosphate) receptor.
J Med Chem. 2005 Feb 24;48(4):1251.
Nantel F, Daull P, Berthiaume N, Duta DN, Blouin A,
Cayer J, Beaudoin M, Belleville K, Benrezzak O, Sirois
P, Battistini B. Integrated in vivo pharmacology
using an instrumented, unrestrained and conscious rat
platform: Application to rat models of diabetes., J
Pharmacol Toxicol Methods. 2005 Nov 6.
Plante GE. Depression and cardiovascular
disease: a reciprocal relationship., Metabolism. 2005
May;54(5 Suppl 1):45-8. Review.
Proulx CD, Simaan M, Escher E, Laporte
SA, Guillemette G, Leduc R.
Involvement of a cytoplasmic-tail serine cluster in
urotensin II receptor internalization., Biochem J. 2005
Jan 1;385(Pt 1):115-23.
Teixeira CF, Jancar S, Lima WT, D'Orleans-Juste
P, Sirois P. Association of
endothelin with lung hemorrhage induced by immune complexes
in rats, Inflammation. 2004 Oct;28(5):253-61.
Tirapelli CR, Al-Khoury J, Bkaily G,
D'Orleans-Juste P, Lanchote VL, Uyemura
SA, de Oliveira AM. Chronic ethanol consumption enhances
phenylephrine-induced contraction in the isolated rat
aorta, J Pharmacol Exp Ther. 2005 Sep 20.
Tirapelli CR, Casolari DA, Yogi A, Montezano AC, Tostes
RC, Legros E, D'Orleans-Juste P, de
Oliveira AM. Functional characterization and expression
of endothelin receptors in rat carotid artery: involvement
of nitric oxide, a vasodilator prostanoid and the opening
of K(+) channels in ET(B)-induced relaxation., Br J
Pharmacol. 2005 Sep 5.
Wolpert C, Schimpf R, Giustetto C, Antzelevitch C, Cordeiro
J, Dumaine R, Brugada R, Hong K, Bauersfeld
U, Gaita F, Borggrefe M.. Further insights into the
effect of quinidine in short QT syndrome caused by a
mutation in HERG., J Cardiovasc Electrophysiol. 2005
Jan;16(1):54-8.
|
|
|
|
 |
|